Ledger.Open graph →
SEC Form D · filed March 24, 2022

Spine BioPharma, Inc

Offering
$30.4M
Sold
$13.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Thomas R. Bumol, Phd · New York, NYDirectorFran R. Magee · New York, NYExecMarc R. Viscogliosi · New York, NYExec · DirectorFrank R. Cammisa, Md · New York, NYDirectorJohn J. Viscogliosi · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗